TOA02, a Recombinant Adenovirus with Tumor-Specific Granulocyte Macrophage Colony-Stimulating Factor Expression, Has Limited Biodistribution and Low Toxicity in Rhesus Monkeys-Reference-Cited by-同舟云学术

TOA02, a Recombinant Adenovirus with Tumor-Specific Granulocyte Macrophage Colony-Stimulating Factor Expression, Has Limited Biodistribution and Low Toxicity in Rhesus Monkeys

Published:2015-04 Issue:2 Volume:26 Page:62-70
ISSN:1946-6536
Container-title:Human Gene Therapy Methods
language:en
Short-container-title:Human Gene Therapy Methods

Author:

Wang Ling¹,Zheng Juecun¹,He Qianchuan²,Yu Xiaoping³,Hu Xiaosong⁴,Deng Shanshan¹,Chang Shuching²,Shen Fubing¹

Affiliation:

1. School of Medical Laboratory Science, Chengdu Medical College, Chengdu 610500, PR China.

2. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.

3. Department of Public Health, Chengdu Medical College, Chengdu 610500, PR China.

4. Department of Morphology Lab, Chengdu Medical College, Chengdu 610500, PR China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics (clinical),Pharmacology,Genetics,Applied Microbiology and Biotechnology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hgtb.2014.144

Reference24 articles.

1. An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors

2. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

3. Nerve-Sparing Therapy with Oncolytic Herpes Virus for Cancers with Neural Invasion

4. Conditionally Replicating Adenoviruses for Cancer Treatment

5. Replication-competent retrovirus vectors for cancer gene therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vector-Mediated Cancer Gene Therapy Reduces Toxicity and Inhibition of Lung Carcinoma Growth in Nude Mice;Applied Biochemistry and Biotechnology;2023-04-29

2. Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses;Expert Opinion on Biological Therapy;2022-11-02

3. Cytokines in oncolytic virotherapy;Cytokine & Growth Factor Reviews;2020-12